ACTA SCIENTIFIC CLINICAL CASE REPORTS

Research Article Volume 5 Issue 1

Effect of Ethyl Acetate Fraction of Lycopene on Immunohistochemistry of Cystatin C in Kidney of Diabetic Wistar Rats

Arayombo Babatunde Elijah* and Arayombo Aramide Femi

Department of Anatomy and Cell Biology, Faculty of Basic Medical Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria

*Corresponding Author: Arayombo Babatunde Elijah, Department of Anatomy and Cell Biology, Faculty of Basic Medical Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.

Received: July 31, 2023; Published: December 05, 2023

Abstract

This research investigated the effect of ethyl acetate fraction of lycopene (EAFL) on immunohistochemistry of Cystatin C in kidney of streptozotocin-induced diabetic wistar rats.
Diabetes Mellitus (DM) is defined as a metabolic disease characterized by chronic hyperglycemia due to absolute or relative insulin deficiency which complications affect virtually all organ systems. The prevalence of the disease has become increasingly rampant worldwide despite avertable, DM and its complications are leading causes of death globally. Thirty six adult male Wistar rats weighing between 120-160 g were used for this study. The rats were divided into 6 groups (A, B, C, D, E and F.) of 6 rats each. Group A was the normal control that received 20 ml/kg/day of citrate buffer intraperitoneally (i.p) for 30 days . Groups B, C, D and E were induced with 60 mg/kg of streptozotocin in citrate buffer intraperitoneally once daily for three days and observed for one week. Group B animals were left untreated, while Groups C, D, E, and F were treated with ethyl acetate fraction of lycopene (EAFL) at dosages of 20, 40, 60 and 20 mg/kg/day via oral route respectively for 30 days. At the end of the experimental period the rats were sacrificed through cervical dislocation. It was concluded that EAFL preserves the macro-anatomy of the kidney and reversed the chronic hyperglycemic state characterizing DM. The distortion in renal histological morphology was reversed and restoration of the histoarchitectural alteration in the treated diabetic animals were observed. Moreover, the renal cystatin C antigen antibody reactions were only accentuated in the untreated diabetic group while no immune reactivity were observed in high dose EAFL.

Keywords: Ethyl Acetate; Lycopene; Immunohistochemistry; Kidney; Diabetes; Wistar Rats

References

  1. American Diabetes Association. “Diagnosis and classification of diabetes mellitus”. Diabetes Care 35.1 (2012): S64-S71.
  2. Bevc S., et al. “Simple cystatin C formula compared to serum creatinine based formula for glomerular filtrationrate in patients with mildly to moderately impaired kidney function”. Kidney Blood Press Research 35 (2012): 649-654.
  3. Chinwe E., et al. “Estimation of blood glucose level and body weight in alloxan induced diabetic rat treated with aqueous extract of Garcinia kola seed”. 1.2 (2015): 26-30.
  4. Cohen L. “A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention”. Experimental Biology Medicine10 (2002): 864-868.
  5. Food and Agricultural Organization of the United Nations (FAO) (2010).
  6. Gelaw BK., et al. “Non adherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital”. Journal of Diabetes Research (2014).
  7. Giovannucci E. “A Prospective Study of Tomato Products, Lycopene, and Prostate Cancer Risk”. JNCI5 (2002): 391-398.
  8. International Diabetes Federation (IDF) Diabetes Atlas 9th Edition (2019).
  9. Jangid H., et al. “An overview on diabetes mellitus”. Asian Journal of Pharmaceutical Research and Development (2017): 11.
  10. “Complications of diabetes – a disease affecting all organs”. 9.2 (2016): 121.129.
  11. Koporec KP., et al. “Hepatoprotective activity of allicin against carbon tetrachloride induced hepatic injury in rats”. Journal of Biological Sciences3 (2006): 457-468.
  12. Kuhad A., et al. “Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain”. European Journal of Pain5 (2008): 624-632.
  13. Livny O., et al. “Lycopene inhibits proliferation and enhances gap-junctional communication of KB-1 human oral tumor cells”. Journal of Nutrition 132 (2002): 3754
  14. Piero MG., et al. “Diabetes mellitus? a devastating metabolic disorder”. Asian Journal of Biomedical and Pharmaceutical Sciences40 (2015).
  15. Rios Ado., et al. “Bixin and lycopene modulation of free radical generation induced by cisplatin-DNA interaction”. Food Chemistry4 (2008): 1113-1118.
  16. Sahin I., et al. “Androgen receptor independent prostate cancer: an emerging clinical entity”. Cancer Biology and Therapy 19 (2017): 347-348.
  17. Global Report on Diabetes, World Health Organization (2016).
  18. About Diabetes: Complications of Diabetes. World Health Organization, Geneva (2016).
  19. Wild S., et al. “Public Health Sciences, University Of Edinburgh, Edinburgh, Scotland”. Diabetes Care5 (2004): 1047-53.
  20. Molitch ME., et al. “Epidemiology of Diabetes Interventions and Complications Study Group: Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes intervention and complications study”. Diabetes Care 33 (2010):

Citation

Citation: Arayombo Babatunde Elijah and Arayombo Aramide Femi. “Effect of Ethyl Acetate Fraction of Lycopene on Immunohistochemistry of Cystatin C in Kidney of Diabetic Wistar Rats". Acta Scientific Clinical Case Reports 5.1 (2024): 03-09.

Copyright

Copyright: © 2024 Arayombo Babatunde Elijah and Arayombo Aramide Femi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US